229.09
price down icon0.39%   -0.89
 
loading
Schlusskurs vom Vortag:
$229.98
Offen:
$229.98
24-Stunden-Volumen:
618.83K
Relative Volume:
0.48
Marktkapitalisierung:
$31.95B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-100.30
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
-2.74%
1M Leistung:
-4.07%
6M Leistung:
+35.60%
1J Leistung:
+44.72%
1-Tages-Spanne:
Value
$228.81
$231.91
1-Wochen-Bereich:
Value
$227.89
$236.33
52-Wochen-Spanne:
Value
$125.38
$246.90

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
229.09 32.07B 2.12B -309.19M 93.57M -2.2841
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
579.45 219.21B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
228.92 162.93B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
676.53 54.48B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
136.07 39.02B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
225.41 38.78B 15.90B 1.28B 2.21B 7.2842

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-02 Fortgesetzt Morgan Stanley Overweight
2025-10-27 Hochstufung BNP Paribas Exane Underperform → Neutral
2025-09-22 Fortgesetzt Wells Fargo Equal Weight
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
03:32 AM

Allspring Global Investments Holdings LLC Sells 47,131 Shares of Natera, Inc. $NTRA - MarketBeat

03:32 AM
pulisher
Dec 31, 2025

Miami man arrested in nearly $1 million theft from tech company he worked for: Cops - NBC 6 South Florida

Dec 31, 2025
pulisher
Dec 31, 2025

Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study - Finviz

Dec 31, 2025
pulisher
Dec 31, 2025

Miami man accused of stealing nearly $1 million from 2 South Florida businesses - WPLG Local 10

Dec 31, 2025
pulisher
Dec 31, 2025

Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Natera CFO sells shares worth $7.76 million - MSN

Dec 31, 2025
pulisher
Dec 30, 2025

Medical stock hovers near buy point after 46% gain - MSN

Dec 30, 2025
pulisher
Dec 30, 2025

Medical Stock Hovers Near Buy Point After 46% Gain - Investor's Business Daily

Dec 30, 2025
pulisher
Dec 30, 2025

Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.

Dec 30, 2025
pulisher
Dec 30, 2025

Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail

Dec 30, 2025
pulisher
Dec 29, 2025

Cwm LLC Increases Stake in Natera, Inc. $NTRA - MarketBeat

Dec 29, 2025
pulisher
Dec 28, 2025

Vontobel Holding Ltd. Increases Stock Position in Natera, Inc. $NTRA - MarketBeat

Dec 28, 2025
pulisher
Dec 28, 2025

Natera is Transforming Patient Care Using AI - Amazon Web Services (AWS)

Dec 28, 2025
pulisher
Dec 27, 2025

Natera: Is Signatera’s Momentum About to Accelerate Again as Biomarker Laws Expand State by State? - Smartkarma

Dec 27, 2025
pulisher
Dec 27, 2025

Natera, Inc. $NTRA Shares Bought by SWS Partners - MarketBeat

Dec 27, 2025
pulisher
Dec 25, 2025

Is Natera’s 486% Three Year Surge Still Justified by Its Fundamentals? - Yahoo Finance

Dec 25, 2025
pulisher
Dec 23, 2025

3 Reasons We’re Fans of Natera (NTRA) - Barchart.com

Dec 23, 2025
pulisher
Dec 23, 2025

3 Reasons We're Fans of Natera (NTRA) - Finviz

Dec 23, 2025
pulisher
Dec 22, 2025

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum - Finviz

Dec 22, 2025
pulisher
Dec 22, 2025

Natera co-founder Sheena Jonathan sells $338913 in stock By Investing.com - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

Natera co-founder Sheena Jonathan sells $338913 in stock - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation - Nasdaq

Dec 22, 2025
pulisher
Dec 22, 2025

Natera (NTRA): Revisiting Valuation After New JAMA Oncology Data on Signatera’s Colorectal Cancer Benefit - simplywall.st

Dec 22, 2025
pulisher
Dec 22, 2025

Natera (NASDAQ:NTRA) Price Target Raised to $285.00 - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com

Dec 22, 2025
pulisher
Dec 20, 2025

Will Natera Inc. stock outperform tech sector in 2025July 2025 Analyst Calls & Real-Time Volume Analysis Alerts - ulpravda.ru

Dec 20, 2025
pulisher
Dec 20, 2025

How Natera Inc. stock performs in stagflationMarket Weekly Review & Precise Entry and Exit Recommendations - ulpravda.ru

Dec 20, 2025
pulisher
Dec 20, 2025

Zevenbergen Capital Investments LLC Sells 11,417 Shares of Natera, Inc. $NTRA - MarketBeat

Dec 20, 2025
pulisher
Dec 20, 2025

Natera (NTRA): Assessing Valuation After a Multi‑Year Share Price Surge - Yahoo Finance

Dec 20, 2025
pulisher
Dec 20, 2025

Natera, Inc. $NTRA Shares Bought by Orion Porfolio Solutions LLC - MarketBeat

Dec 20, 2025
pulisher
Dec 20, 2025

Did Strong New Signatera ctDNA Data Just Shift Natera’s (NTRA) Investment Narrative? - simplywall.st

Dec 20, 2025
pulisher
Dec 19, 2025

How Investors Are Reacting To Natera (NTRA) Trial Data Showing Signatera’s 40% Risk Reduction In CRC - Yahoo Finance

Dec 19, 2025
pulisher
Dec 19, 2025

Dir Sheena Files To Sell 4,500 Of Natera Inc [NTRA] - TradingView — Track All Markets

Dec 19, 2025
pulisher
Dec 19, 2025

Can Natera Inc. stock beat analyst upgradesJuly 2025 Snapshot & Weekly High Return Opportunities - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Natera’s 425.8% Three Year Surge Still Supported by Its Growth Story in 2025? - simplywall.st

Dec 19, 2025
pulisher
Dec 18, 2025

Is Natera Inc. stock a safe buy before earningsQuarterly Profit Summary & Weekly High Conviction Trade Ideas - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Profit Recap: Will Natera Inc. stock outperform tech sector in 20252025 Biggest Moves & Growth Focused Entry Point Reports - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

NTRA: Natera's Phase III Study Highlights Celecoxib's Efficacy i - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Study shows celecoxib improves survival in certain colorectal cancer patients - Investing.com India

Dec 18, 2025
pulisher
Dec 18, 2025

Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer - New Castle News

Dec 18, 2025
pulisher
Dec 18, 2025

Is Natera Inc. stock attractive after correctionJuly 2025 Opening Moves & Weekly Chart Analysis and Guides - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Thrivent Financial for Lutherans Cuts Stake in Natera, Inc. $NTRA - MarketBeat

Dec 18, 2025
pulisher
Dec 18, 2025

Assenagon Asset Management S.A. Purchases 80,684 Shares of Natera, Inc. $NTRA - MarketBeat

Dec 18, 2025
pulisher
Dec 17, 2025

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail

Dec 17, 2025
pulisher
Dec 17, 2025

Natera (NTRA) director and co-founder discloses stock gift and sales - Stock Titan

Dec 17, 2025
pulisher
Dec 17, 2025

Dir Sheena Sells 3,070 ($696.9K) Of Natera Inc [NTRA] - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 17, 2025

Natera’s Signatera Test Gains Validation in Key Breast Cancer Study - AD HOC NEWS

Dec 17, 2025
pulisher
Dec 17, 2025

Dir Sheena Files To Sell 9,210 Of Natera Inc [NTRA] - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 17, 2025

Natera, Inc.'s (NASDAQ:NTRA) Business Is Trailing The Industry But Its Shares Aren't - 富途牛牛

Dec 17, 2025
pulisher
Dec 16, 2025

Solomon Moshkevich Sells 4,692 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat

Dec 16, 2025
pulisher
Dec 16, 2025

Insider Selling: Natera (NASDAQ:NTRA) Director Sells 48,419 Shares of Stock - MarketBeat

Dec 16, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research MTD
$1,394.19
price down icon 1.42%
diagnostics_research IQV
$225.41
price down icon 1.00%
diagnostics_research A
$136.07
price down icon 1.13%
diagnostics_research WAT
$379.83
price down icon 1.08%
diagnostics_research LH
$250.88
price down icon 0.87%
Kapitalisierung:     |  Volumen (24h):